
Delaware Crossing Investor Group
North America, Pennsylvania, United States, Doylestown
Description
Delaware Crossing Investor Group enables its network of executives and entrepreneurs to invest in early-stage and growth-oriented companies.
Investor Profile
Delaware Crossing Investor Group has backed more than 15 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Manufacturing.
Stage Focus
- Seed (47%)
- Series Unknown (20%)
- Series A (20%)
- Convertible Note (7%)
- Pre Seed (7%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Manufacturing
- Software
- Therapeutics
- Pharmaceutical
- Automotive
- Electronics
- Semiconductor
- Wearables
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.